Union Jobs Report

PILMA news

IAFF General President’s Letter to U.S. Secretary of Commerce on WTO

On Jan 22, 2024, IAFF General President, Edward Kelly, sent the following letter to the Honorable Gina Raimondo on changes to the WTO. Download the letter here. January 22, 2024 Dear Secretary Raimondo, The International Association of Fire Fighters represents 343,000 fire fighters, paramedics, and officers across our nation. Our

Read More »

Drug Pricing Policies Put American Jobs at Risk

This article originally appeared on RealClearHealth.com When you think of the biopharmaceutical industry, you might think of people in lab coats conducting research. What might not immediately come to mind are the men and women who build the labs and manufacturing facilities that these researchers rely on. America’s biopharmaceutical sector relies

Read More »

Facility Tours

PHILADELPHIA STEAMFITTERS LOCAL 420 TRAINING CENTER 

Maryland Senator Chris Van Hollen Tours IBEW Local 26

Congressman Tom MacArthur Tours IUOE Local 825 in Dayton, NJ

LillyPad: Why Businesses and Labor Need to Work Together

Governor Gina M. Raimondo Tours UA Local 51 East Providence Facility

Senator Murphy Tours SMART Local 40 with PILMA in Connecticut

Partnership Between Pharmaceutical Industry and Labor Creates Good Jobs

Senator Dick Durbin, Chicago-Area Industry and Labor Leaders Tour Chicago Pipefitters Local 597 Training Facility

PILMA Cohosts Senator Menendez Tour of New Jersey Iron Workers Training Facility

Resolutions

Reports

PRESS RELEASE New Study Demonstrates Critical Role of American Workers in Building Life-Saving Medicine Infrastructure

RESOLUTION Concerning the Misuse and Needed Reform of the Federal 340B Drug Pricing Program

Statement on Executive Order

The Feds must stop going easy on foreign patent thieves who hurt Pennsylvania | Opinion

PILMA Applauds Reintroduction of the Ensuring Pathways to Innovative Cures (EPIC) Act

President McManus Letter on PBMs to Congress

United Association President McManus Letter to HELP Committee

STATEMENT CONCERNING CMS’ Announcement of 10 Drugs Selected for 2026 Government Price Controls

STATEMENT Supporting the House Oversight Committee Hearings on PBM Transparency and Accountability